Influenza Vaccination Market Report

Global and China Influenza Vaccination Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 16, 2022
  • PAGES：142
  • REPORT CODE：GMM1379701
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches.

    Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

    This report elaborates on the current development of the Influenza Vaccination industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sanofi (Europe)

    • Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • AstraZeneca (Europe)

    • Hualan Biological Engineering Inc (Asia Pacific)

    • F Hoffmann-La Roche Ltd (Europe)

    • Novartis AG (Europe)

    • GlaxoSmithKline plc (Europe)

    • DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • BioCryst Pharmaceuticals, Inc (US)

    • Abbott (US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Egg Based

    • Cell Culture

    • Recombinant

    Application:

    • Hospitals

    • Research Organizations

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Influenza Vaccination Industry Overview

      • 1.1.1 Influenza Vaccination Market Scope and Market Segments

      • 1.1.2 Influenza Vaccination Industry Characteristics

      • 1.1.3 Global and China Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Influenza Vaccination Production Value and Growth Rate (2017-2028)

    • 1.2 Global Influenza Vaccination Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Egg Based

      • 1.2.2 Cell Culture

      • 1.2.3 Recombinant

    • 1.3 Global Influenza Vaccination Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Research Organizations

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Influenza Vaccination Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Influenza Vaccination Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Influenza Vaccination Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Influenza Vaccination Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Influenza Vaccination Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Influenza Vaccination Industry Porter's Five Forces Model Analysis

      • 2.2.3 Influenza Vaccination Industry PEST Analysis

    • 2.3 Influenza Vaccination Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Influenza Vaccination Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Influenza Vaccination Industry

    Chapter 3 Global and China Influenza Vaccination Market, by Manufacturer

    • 3.1 Global and China Influenza Vaccination Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Influenza Vaccination Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Influenza Vaccination Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Influenza Vaccination Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Influenza Vaccination Market Top 3 Players

    Chapter 4 Global and China Influenza Vaccination Market, by Type (2017-2028)

    • 4.1 Influenza Vaccination Market Trend, by Type

    • 4.2 Global Influenza Vaccination Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Influenza Vaccination Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Influenza Vaccination Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Influenza Vaccination Price Trend, by Type (2017-2028)

    • 4.3 China Influenza Vaccination Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Influenza Vaccination Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Influenza Vaccination Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Influenza Vaccination Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Influenza Vaccination Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Influenza Vaccination Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Influenza Vaccination Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Influenza Vaccination Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Influenza Vaccination Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Influenza Vaccination Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Influenza Vaccination Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Influenza Vaccination Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Influenza Vaccination Market Analysis

    • 7.1 North America Influenza Vaccination Market, by Type

    • 7.2 North America Influenza Vaccination Market, by Application

    • 7.3 North America Influenza Vaccination Market Analysis and Forecast, by Country

      • 7.3.1 United States Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Influenza Vaccination Market Analysis

    • 8.1 Europe Influenza Vaccination Market, by Type

    • 8.2 Europe Influenza Vaccination Market, by Application

    • 8.3 Europe Influenza Vaccination Market Analysis and Forecast, by Country

      • 8.3.1 Germany Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Influenza Vaccination Market Analysis

    • 9.1 APAC Influenza Vaccination Market, by Type

    • 9.2 APAC Influenza Vaccination Market, by Application

    • 9.3 APAC Influenza Vaccination Market Analysis and Forecast, by Country

      • 9.3.1 China Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Influenza Vaccination Market Analysis

    • 10.1 Latin America, Middle East and Africa Influenza Vaccination Market, by Type

    • 10.2 Latin America, Middle East and Africa Influenza Vaccination Market, by Application

    • 10.3 Latin America, Middle East and Africa Influenza Vaccination Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Influenza Vaccination Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Influenza Vaccination Company Profiles

      • 11.1 Sanofi (Europe)

        • 11.1.1 Sanofi (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sanofi (Europe) Influenza Vaccination Product Profiles, Application and Specification

        • 11.1.3 Sanofi (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

        • 11.2.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product Profiles, Application and Specification

        • 11.2.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 AstraZeneca (Europe)

        • 11.3.1 AstraZeneca (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 AstraZeneca (Europe) Influenza Vaccination Product Profiles, Application and Specification

        • 11.3.3 AstraZeneca (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Hualan Biological Engineering Inc (Asia Pacific)

        • 11.4.1 Hualan Biological Engineering Inc (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product Profiles, Application and Specification

        • 11.4.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 F Hoffmann-La Roche Ltd (Europe)

        • 11.5.1 F Hoffmann-La Roche Ltd (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product Profiles, Application and Specification

        • 11.5.3 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis AG (Europe)

        • 11.6.1 Novartis AG (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis AG (Europe) Influenza Vaccination Product Profiles, Application and Specification

        • 11.6.3 Novartis AG (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline plc (Europe)

        • 11.7.1 GlaxoSmithKline plc (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline plc (Europe) Influenza Vaccination Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline plc (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

        • 11.8.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Product Profiles, Application and Specification

        • 11.8.3 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 BioCryst Pharmaceuticals, Inc (US)

        • 11.9.1 BioCryst Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Product Profiles, Application and Specification

        • 11.9.3 BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Abbott (US)

        • 11.10.1 Abbott (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Abbott (US) Influenza Vaccination Product Profiles, Application and Specification

        • 11.10.3 Abbott (US) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Influenza Vaccination Industry Investment Prospect and Risk Assessment

    • 12.1 Influenza Vaccination Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Influenza Vaccination Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure China Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Global Influenza Vaccination Production Value and Growth Rate (2017-2028)

    • Figure China Influenza Vaccination Production Value and Growth Rate (2017-2028)

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Egg Based (2017-2028)

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Cell Culture (2017-2028)

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Recombinant (2017-2028)

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Research Organizations (2017-2028)

    • Figure North America Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Vaccination Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Influenza Vaccination Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Influenza Vaccination Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Influenza Vaccination Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Influenza Vaccination Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Influenza Vaccination Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Influenza Vaccination Market Share, by Manufacturer in 2021

    • Figure Global and China Influenza Vaccination Market Share, by Manufacturer in 2022

    • Table Global Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table Global Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure Global Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table Global Influenza Vaccination Sales Value, by Type (2017-2028)

    • Table Global Influenza Vaccination Sales Value Share, by Type (2017-2028)

    • Figure Global Influenza Vaccination Price Trend, by Type (2017-2028)

    • Table China Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table China Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure China Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table China Influenza Vaccination Sales Value, by Type (2017-2028)

    • Table China Influenza Vaccination Sales Value Share, by Type (2017-2028)

    • Figure China Influenza Vaccination Price Trend, by Type (2017-2028)

    • Table Global Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table Global Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure Global Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Table Global Influenza Vaccination Sales Value, by Application (2017-2028)

    • Table Global Influenza Vaccination Sales Value Share, by Application (2017-2028)

    • Figure Global Influenza Vaccination Sales Value Share, by Application (2017-2028)

    • Table China Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table China Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure China Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Table China Influenza Vaccination Sales Value, by Application (2017-2028)

    • Table China Influenza Vaccination Sales Value Share, by Application (2017-2028)

    • Figure China Influenza Vaccination Sales Value Share, by Application (2017-2028)

    • Figure China Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • Figure North America Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Influenza Vaccination Production, Import, Consumption and Export (2017-2022)

    • Table North America Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table North America Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure North America Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table North America Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table North America Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure North America Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure United States Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure United States Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Canada Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Table Europe Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table Europe Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure Europe Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table Europe Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table Europe Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure Europe Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure Germany Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure UK Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure UK Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure France Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure France Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Italy Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Spain Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Poland Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Russia Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Table APAC Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table APAC Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure APAC Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table APAC Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table APAC Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure APAC Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure China Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure China Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Japan Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure India Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure India Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Vaccination Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Vaccination Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Vaccination Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Vaccination Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Influenza Vaccination Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Influenza Vaccination Sales Value and Growth Rate (2017-2028)

    • Table Sanofi (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi (Europe) Product Profiles, Application and Specification

    • Table Sanofi (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Product Profiles, Application and Specification

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca (Europe) Product Profiles, Application and Specification

    • Table AstraZeneca (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hualan Biological Engineering Inc (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hualan Biological Engineering Inc (Asia Pacific) Product Profiles, Application and Specification

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd (Europe) Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG (Europe) Product Profiles, Application and Specification

    • Table Novartis AG (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc (Europe) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc (Europe) Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Product Profiles, Application and Specification

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioCryst Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioCryst Pharmaceuticals, Inc (US) Product Profiles, Application and Specification

    • Table BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott (US) Product Profiles, Application and Specification

    • Table Abbott (US) Influenza Vaccination Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US